This site is intended for healthcare professionals only
LoginRegister
GSK Blenrep combos receive positive EMA Committee opinion in relapsed/refractory multiple myelomaGSK Shingrix new prefilled syringe presentation accepted for review by EMA
Sun Pharma Names Sana Shaikh as Head of MarketingSun Pharma Labs Gets CDSCO Panel Nod Phase-III clinical trial of Semaglutide solution for injection
AstraZeneca Saphnelo subcutaneous self-administration recommended for approval in EU by CHMP for systemic lupus erythematosusAstraZeneca gets CDSCO Panel nod to study Palivizumab solution for injection
Torrent Pharma Gets Zero USFDA Observations for Dahej PlantUSFDA nod to Leqembi IV maintenance dosing for treatment of early Alzheimer's Disease: Eisai, Biogen
Biopharma SHAKTI Gets Industry Backing as Budget 2026 Pushes India’s ₹10,000 Crore Biopharma AmbitionBiocon S&P Global ESG score improves to 69 for 2024
Zydus Lifesciences Chairman Pankaj R Patel conferred with Padma BhushanZydus Lifesciences Chairman Pankaj R Patel conferred with Padma Bhushan
CDSCO Declares 74 Medicines, APIs and Devices Samples Not of Standard Quality in December84 Formulations declared Not of Standard Quality as per data provided by states: CDSCO Drug Alert
USFDA grants priority review to Sanofi-Regeneron Dupixent for bullous pemphigoidSanofi Sarclisa approved in EU for newly diagnosed multiple myeloma
Roche unveils new PCR test to improve Vaginitis Diagnosis in countries following CE MarkRoche receives USFDA clearance with CLIA waiver for cobas liat sexually transmitted infection...
Strides Pharma Gets USFDA EIR for New York Plant, Inspection Closed With VAIStrides Pharma debuts with stellar ESG rating of 76/100 in S&P Global CSA 2024
No Eligible Successor: Centre Clarifies DCGIs Contractual ReappointmentDr Raghuvanshi To Continue as DCGI Amidst Search For Successor, 18 Candidates Vie For Top Post
CDSCO Declares 74 Medicines, APIs and Devices Samples Not of Standard Quality in DecemberDrug Alert: CDSCO Flags 51 Formulations As Not Of Standard Quality
X